Eden News

Eden is pleased to announce the appointment of Dr. Michael Carroll as Director of Regulatory Affairs. 

Mike is a leading figure in the field of crop protection products development and registration. He brings international experience to the team having worked in the UK, Germany, Belgium and the USA, with over 30 years' experience gained in the agrochemical industries. Mike served tenures of over 10 years at both Dow AgroSciences and Monsanto Agricultural Group, holding the various positions including Global Registration Manager and European Registration Manager. At Monsanto and Dow AgroSciences, Mike's responsibilities included the global launch of herbicides and fungicides, experience which will be highly relevant as Eden executes on plans to expand its product offering. 

More recently, Mike served as Head of Research and Development for Arysta EMEA, the largest region in Arysta LifeSciences. He was responsible for early stage development and registration of new formulations, the defence of existing active substances, chemical and biosolutions, and ensuring REACH (Registration, Evaluation, Authorisation and restriction of Chemicals) compliance in Europe. For the past year, Michael has been working for TSG Consulting(AIM:SAG) an AIM-quoted Science Group company that provides regulatory and scientific support to chemical companies around the world.

Mike holds BSc and PhD degrees in biochemistry from the UK universities of Bath and London, respectively, and throughout his career has shown interest in how local politics ultimately controls the regulatory process. Mike is a frequent speaker and published author, regularly participating in Informa Ag Chem and Generics speciality conferences and British Crop Production Council conferences. In 2019, he presented at both of these events on the topic of "The EU General Food Law and Transparency".

CEO Sean Smith commented: "Mike is a key appointment that further demonstrates our focus on building a high-calibre team around the core functions within our business. He brings significant capabilities to the Company in the critical areas of product registration and regulatory compliance.  Mike has a wealth of international experience which has given him invaluable expertise in product registration globally.  Mike comes with a long track record of driving successful regulatory outcomes in the crop protection industry, a network of key industry influencers, and experience in senior roles at industry leaders such as Dow AgroSciences and Monsanto. We are pleased to welcome him to Eden."

Eden is pleased to announce that our foliar biofungicide product Mevalone™, branded "3LOGY®" in Italy and "Araw®" in Spain, has received certification for use in organic farming. The certification, received by Eden's partner Sipcam Oxon S.p.A ("Sipcam"), follows the initial approval of Eden's three EU-registered active ingredients for use in organic farming earlier this year.

Eden's partner Sipcam has been selling 3LOGY and Araw for the primary use of treating and preventing botrytis. Botrytis is a widespread fungal disease that causes grey mould on many fruits and vegetables leading to the rapid loss of commercially valuable crops. Following certification, the product can now also be used in organic vineyards, creating a significant opportunity for Eden to enter a new market. Spain and Italy are in the top three EU countries with the largest organic farming areas; Spain has the overall largest area of permanent crops (e.g. grapes, olives, nuts). More specifically, Spain and Italy each have more than 100,000 hectares of organic grapes harvested across the country, followed by France with over 78,000 hectares. It is anticipated that an equivalent inclusion will soon be received by Eden's partner Sumi Agro in France. 

As consumer sentiment for sustainable and organic products has grown in recent years, the European viniculture industry has increased its attention and commitment to sustainability and protecting the environment. Europe will account for 78% of the global organic wine market by 2022, and globally the market is projected to grow at 9.2% CAGR from 2017-22. In the UK, consumers are willing to pay 38% more for organic wine and there is a broad audience of environmentally conscious consumers who now opt for a grape with a greener footprint.

Sean Smith, Chief Executive Officer of Eden, said: "We are pleased to begin selling our products to organic growers in Italy and Spain, a commercial development that will contribute to the enlargement of our addressable market in Europe and to the ongoing growth of sales in these important countries. Sustainable farming practices are clearly a priority for wine producers globally as the organic wine market has increased rapidly over recent years. Italy and Spainare at the centre of the movement, with organic wine production forecast to increase by 70% in Spain between 2018-2023 and Italy's organic vineyards amount for 15.5% of its total vineyards, the highest amount in the world. Our products give organic growers an effective and sustainable solution comparable to conventional chemistry but in a way that is aligned with the fundamental elements of organic production."

Eden proposes to raise, subject to certain conditions (i) £10.1 million (before expenses) by the conditional Placing and Subscription of 168,333,334 new Ordinary Shares at the Issue Price to certain institutional and other investors including Sipcam; and (ii) up to approximately £0.5 million (before expenses) by way of an Open Offer made to Qualifying Shareholders of up to 8,287,573 new Ordinary Shares at the Issue Price.

The net proceeds of the Placing, Subscription and Open Offer will be used to advance the development, registration and commercialisation of new product categories, including new insecticide formulations and seed treatments, as well as to provide additional working capital for the Group associated with the new development areas.

A General Meeting will be held at DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF at 11.00 a.m. on 18 March 2020.

Further details can be found here.

Today Eden announces a one year exclusive evaluation agreement with Corteva Agriscience.

Corteva will evaluate Eden's Sustaine^TM technology and terpenes in seed treatment applications. The multi-billion dollar seed treatment sector is forecast to grow at 9.8% CAGR to 2024 and biological solutions in particular are in demand. 

For full details of the announcement, please click here.

Eden's three terpene active ingredients - thymol, eugenol and geraniol - have been granted organic approval in the EU.

This news starts the new year with a bang as the organic sector is experiencing continued strong growth. In the last 10 years the area under organic production has increased by 70% in the EU alone. Globally, the EU is the second largest consumer of organic products, with the annual value reaching over €34billion. 

For full details of the announcement, please click here.

Eden's commercial partner Sipcam will now distribute and sell Mevalone in Portugal and Benelux (subject to regulatory approval in Benelux). 

Growers will benefit from both strong product performance and the considerable expertise to support it, which Sipcam has developed in Italy and Spain (where Mevalone is branded as 3logy and ARAW).

Portugal ranks 9th in the world for area under vines and is a key market for Eden's Mevalone bio-fungicide.

For full details of the announcement, please click here.

Mexico has authorised the use of Cedroz on a wide range of crops, including tomatoes, potatoes, peppers, eggplants, melons, chili peppers, pepinos and squash. Significantly, Mexico is the largest exporter of tomatoes globally, as well as being the largest supplier of agricultural products to the U.S.

This first entry into the Americas is a positive development for Cedroz and Eden's Sustaine^TM encapsulation technology and represents increasing demand for more sustainable solutions in agriculture.

For full details of the announcement, please click here.

Eden is pleased to announce a new distribution agreement with SumiAgro Europe which allows SAE the exclusive right to sell Eden's fungicide product, Mevalone, in five new markets across central Europe, including Germany and Poland.

The agreements includes treatment of grapes against Botrytis and treatment of apples against post-harvest storage diseases.

For full details of the announcement, please click here.

Eden is pleased to announce that it has been highly commended in two categories in the 2019 Agrow Awards.

Sustaine™ was highly commended in the Best New Formulation Category. 

Sustaine™ is a novel, patented encapsulation solution for a wide range of currently registered agrochemicals. Sustaine™ capsules are naturally sourced biodegradable micro-spheres producing stablished aqueous emulsions which, are easy to mix and apply, safer to the environment and have reduced phytotoxicity. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem.

Mevalone™ was highly commended in the Best New Biopesticide category. 

Mevalone™ is a unique biofungicide based on natural plant chemistry, successfully utilised by growers as a valuable part of their crop protection programmes. Developed by Eden Research plc and distributed via commercial partners across Europe and Kenya, Mevalone provides an invaluable tool to tackle Botrytis cinerea. The antifungal activity of a combination of three plant terpenes is harnessed by Eden’s patented microencapsulation technology, Sustaine™. Solvent free, residue exempt, efficacious and price competitive, Mevalone represents a significant step forward in the development of new and reliable, biological crop protection technology.

https://agribusinessintelligence.informa.com/events-and-webinars/events/crop-science-forum-and-awards

Eden Research plc (AIM: EDEN), the AIM listed company that develops and supplies breakthrough biopesticide products and natural, plastic- free microencapsulation technologies to the global crop protection, animal health and consumer products industries, announces that Sean Smith, CEO, has today purchased 114,313 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 8.3 pence.

Following this purchase, Mr Smith holds 547,706 Ordinary Shares representing approximately 0.26 per cent. of the Company's issued share capital.

For full details please click here.